Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 3,390.00
-160.00 (-4.51%)
May 21, 2026, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 124.87 billion as of May 21, 2026. Its market cap has decreased by -30.39% in one year.
Market Cap
124.87B
Enterprise Value
-233.99B
Revenue
31.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,390.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 124.87B, a decrease of -53.60%. That is a compound annual growth rate of -5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 124.87B | -6.58% |
| Dec 30, 2025 | 133.66B | -26.78% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 61.89T |
| Celltrion | 37.60T |
| ALTEOGEN | 19.24T |
| Samsung Epis Holdings | 11.56T |
| DRTECH | 133.73B |
| Jeil Pharma Holdings | 132.48B |
| Amicogen | 132.45B |
| Shinhung | 129.10B |